QES Group Berhad (0196.KL)

MYR 0.41

(1.25%)

EBITDA Summary of QES Group Berhad

QES Group Berhad's latest annual EBITDA in 2023 was 33.26 Million MYR , down -17.82% from previous year.
QES Group Berhad's latest quarterly EBITDA in 2024 Q2 was 10.65 Million MYR , up 101.87% from previous quarter.
QES Group Berhad reported an annual EBITDA of 40.64 Million MYR in 2022, up 32.89% from previous year.
QES Group Berhad reported an annual EBITDA of 30.49 Million MYR in 2021, up 85.79% from previous year.
QES Group Berhad reported a quarterly EBITDA of 5.62 Million MYR for 2024 Q1, down -16.11% from previous quarter.
QES Group Berhad reported a quarterly EBITDA of 11.64 Million MYR for 2023 Q2, up 40.71% from previous quarter.

Annual EBITDA Chart of QES Group Berhad (2023 - 2019)

Historical Annual EBITDA of QES Group Berhad (2023 - 2019)

Year	EBITDA	EBITDA Growth
2023	33.26 Million MYR	-17.82%
2022	40.64 Million MYR	32.89%
2021	30.49 Million MYR	85.79%
2020	14.57 Million MYR	785.96%
2019	7.28 Million MYR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	10.65 Million MYR	101.87%
2024 Q1	5.62 Million MYR	-16.11%
2023 Q2	11.64 Million MYR	40.71%
2023 Q4	5.91 Million MYR	-20.6%
2023 Q1	8.27 Million MYR	55.86%
2023 FY	- MYR	-17.82%
2023 Q3	7.45 Million MYR	-36.02%
2022 Q3	14.58 Million MYR	0.0%
2022 FY	- MYR	32.89%
2022 Q4	5.31 Million MYR	-63.6%
2021 FY	- MYR	85.79%
2020 FY	- MYR	785.96%
2019 FY	- MYR	0.0%

Peer EBITDA Comparison of QES Group Berhad

Name	EBITDA	EBITDA Difference
Artroniq Berhad	-695 Thousand MYR	4886.187%
Optimax Holdings Berhad	28.58 Million MYR	-16.369%
Pharmaniaga Berhad	7.34 Million MYR	-352.695%
Apex Healthcare Berhad	441.93 Million MYR	92.473%